Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Expand
titleGET /loans/gross-book-value-evidence (153-WM_LN-A_Mortgage)

The following table shows for deal "153-WM_LN-A_Mortgage" expected results relevant for the gross-book-value-evidence at different posting dates. 

For the explanation of the data fields see here.



dailyPayableNominalamortisedCostBal28495.91
postingDate1331/0903/201820191420/09/201830/09/201803/201931/1201/2018201902/01/201931/01/201920/03/201931/03/2019/12/201830/09/201814/09/201813/09/2018
companyId11111111
dealId001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity001-FK_LN-A-Consumer-Annuity
gaapIFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9IFRS9
currencyDeal EUREUREUREUREUREUREUREUR
contractualRemainingCapital0-3300027936,25-33000-30459.4427936,25-29621.,53-29621.,53-27936.2530459,44-27936.25contractualRemainingCapitalBal33000,00-33000,000,00
-33000contractualRemainingCapitalBal-3300027936,25-30459.4427936,25-29621.,53-29621.,53-27936.2530459,44-27936.2533000,00-33000,000,00
0dailyPayableNominal0,000,000,000,000,000,000,000,00
dailyPayableNominalBal0,000,000,000,000,000,000,000,00
dailyPayableInterest0,000,000,000,000,000,000,000,00
dailyPayableInterestBal0,000,000,000,000,000,000,000,00
dailyPayableCharge 0,000,000,000,000,000,000,000,00
dailyPayableChargeBal0,000,000,000,000,000,000,000,00
accruedInterestLinearInArrears173,28113,53177,400,000175,90112.,93175.90,000177.4,00
accruedInterestLinearInArrearsBal173,28113.,53173.28accruedInterestLinearInArrearsBal177,400,000175,90112.,93175.90177.4113.53173.280,000,00
effectiveInterestRate7.6725341036,677.6725341036,677.6725341036,677.6725341036,677.6725341036,677.6725341036,677.6725341036,677.6725341036,67
amortisedCost0-3300027936,25-33000-30459.4427936,25-29621.,53-29621.,53-27936.2530459,44-27936.2533000,00-33000,000,00
-33000amortisedCostBal-3300027936,25-30459.4427936,25-29621.,53-29621.,53-27936.25-27936.2530459,44-33000,00-33000,000,00
accruedChargesInAdvance0,000,000,000,000,000,000,000,00
accruedChargesInAdvanceBal0,000,000,000,000,000,000,000,00
accruedChargesInArrears0,000,000,000,000,000,000,000,00
accruedChargesInArrearsBal0,000,000,000,000,000,000,000,00
accruedPremiumDiscount0,000,000,000,000,000,000,000,00
accruedPremiumDiscountBal0,000,000,000,000,000,000,000,00
interestSmoothing00-1.762.962.816.55-10.02-4.87
interestSmoothingBal00-1.762.962.816.55-10.02-4.87
fairValueDcf033002.0333113.5930642.4829628.4530247.328440.5928495.91
fairValueDcfBal033002.0333113.5930642.4829628.4530247.328440.5928495.91
fairValueDcfConstantCreditSpread033002.0333113.5930642.4829628.4530247.328440.5928495.91
fairValueDcfConstantCreditSpreadBal033002.0333113.5930642.4829628.4530247.328440.59-4,87-10,026,552,812,96-1,760,000,00
interestSmoothingBal-4,87-10,026,552,812,96-1,760,000,00
fairValueDcf28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
fairValueDcfBal28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
fairValueDcfConstantCreditSpread28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
fairValueDcfConstantCreditSpreadBal28495,9128440,5930247,3029628,4530642,4833113,5933002,030,00
stageShortNameHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHYHEALTHY
stageDescriptionLow credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)Low credit risk (Initial recognition)
eclAmountBal-210,79-247.45210,30-247.5223,54-248.33222,18-229.,79-222.18248,33-223.54-210.3-210.79247,50-247,45
unwinding0,000,000,000,000,000,000,000,00
unwindingBal0,000,000,000,000,000,000,000,00




Expand
titleGET /loans/accounting-transaction-related-accounting-ratios (153-WM_LN-A_Mortgage)

The following table shows for a

  • specific tenant (companyId) and for
  • deal (dealId) "153-WM_LN-A_Mortgage" and for 
  • GAAP (gaap) "IFRS"

accounting transactions at various posting dates (postingDate)

For the explanation of the data fields see here.



postingDate accountingTransactionmeasureOrRatioDescriptionsignOfMeasureOrRatioamountAccountingRatiocurrencyTransactionamountAccountingRatioBalbankClientcustomerTypeproductaccountingCategoryimpairmentStageimpairmentType
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
13/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-0EUR00Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout ContractualCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Capital Payout Real PaymentCapital amount-33000EUR330000Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.45EUR247.450Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
14/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+247.5EUR247.50Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
30/09/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-1.76EUR1.760Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+112.93EUR112.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Real RepaymentCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+812.8EUR812.80Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+820.91EUR820.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Capital Repayment ContractualCapital amount+906.85EUR906.850Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+248.33EUR248.330Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears ContractualCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+119.99EUR119.990Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+205.93EUR205.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/12/2018LN A Incoming Interest in Arrears Real PaymentsCapital amount+214.04EUR214.040Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+175.9EUR175.90Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.96EUR2.960Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Real RepaymentCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Capital Repayment ContractualCapital amount+837.91EUR837.910Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+229.79EUR229.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears ContractualCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
02/01/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+188.93EUR188.930Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+2.81EUR2.810Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+222.18EUR222.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/01/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+177.4EUR177.40Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation+6.55EUR6.550Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Real RepaymentCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+842.18EUR842.180Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Capital Repayment ContractualCapital amount+843.1EUR843.10Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+223.54EUR223.540Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears ContractualCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+183.74EUR183.740Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
20/03/2019LN A Incoming Interest in Arrears Real PaymentsCapital amount+184.66EUR184.660Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-10.02EUR10.020Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+113.53EUR113.530Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsAccrual/deferral of interest+173.28EUR173.280Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Accrual Incoming Interest in ArrearsDifference between contractual and effective interest rate excl. amortisation-4.87EUR4.870Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.+210.3EUR210.30Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)
31/03/2019LN A Expected Loss Stage 1 (AC)Posting Expected Credit Loss (ECL) pl INTEREST RATE INSTR.-210.79EUR210.790Private Customeryour product nameIFRS 9 Amortised Cost1The type of impairment is used for deals in stage 1 (HEALTHY)


...